Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study

Asthma and COPD in cystic fibrosis intron-8 5T carriers. A population-based study

Bibliographic Details
Main Authors:	Dahl, Morten, Tybjærg-Hansen, Anne, Lange, Peter, Nordestgaard, Børge G
Format:	Online
Language:	English
Published:	BioMed Central 2005
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1277850/

Similar Items

A Population-based Study of Morbidity and Mortality in Mannose-binding Lectin Deficiency
by: Dahl, Morten, et al.
Published: (2004)

Heterozygosity for E292V in ABCA3, lung function and COPD in 64,000 individuals
by: Bækvad-Hansen, Marie, et al.
Published: (2012)

Cost-Effectiveness of Carrier Screening for Cystic Fibrosis in Australia
by: Norman, Richard, et al.
Published: (2012)

Perceptions of Population Cystic Fibrosis Prenatal and Preconception Carrier Screening Among Individuals with Cystic Fibrosis and Their Family Members
by: Maxwell, Susannah, et al.
Published: (2011)

Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population
by: Ørsted, David Dynnes, et al.
Published: (2007)

Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study
by: Christoffersen, Mette, et al.
Published: (2011)

Population-Based Resequencing of APOA1 in 10,330 Individuals: Spectrum of Genetic Variation, Phenotype, and Comparison with Extreme Phenotype Approach
by: Haase, Christiane L., et al.
Published: (2012)

ABC Transporter Genes and Risk of Type 2 Diabetes: A study of 40,000 individuals from the general population
by: Schou, Jesper, et al.
Published: (2012)

Allergic Bronchopulmonary Aspergillosis in Asthma and Cystic Fibrosis
by: Knutsen, Alan P., et al.
Published: (2011)

Data on plasma levels of apolipoprotein E, correlations with lipids and lipoproteins stratified by APOE genotype, and risk of ischemic heart disease
by: Rasmussen, Katrine L., et al.
Published: (2016)

Elevated Transferrin Saturation and Risk of Diabetes: Three population-based studies
by: Ellervik, Christina, et al.
Published: (2011)

Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis
by: Kalina R. Atanasova, et al.
Published: (2018-08-01)

A case report of ABPA, cystic fibrosis and asthma treated with omalizumab
by: Mazza, JA, et al.
Published: (2015)

Correlation of Anxiety-Depression and Sleep Quality in Mothers of Children with Cystic Fibrosis and Asthma
by: Safa, Mitra, et al.
Published: (2012)

Preferences for Prenatal Tests for Cystic Fibrosis: A Discrete Choice Experiment to Compare the Views of Adult Patients, Carriers of Cystic Fibrosis and Health Professionals
by: Hill, Melissa, et al.
Published: (2014)

Human Genetics Society of Australasia Position Statement: Population-Based Carrier Screening for Cystic Fibrosis
by: Delatycki, M., et al.
Published: (2014)

Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel
by: Watson, Michael S., et al.
Published: (2004)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
by: Bergin, David A, et al.
Published: (2013)

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
by: Schmidt, Béla Z, et al.
Published: (2016)

The Effect of Elevated Body Mass Index on Ischemic Heart Disease Risk: Causal Estimates from a Mendelian Randomisation Approach
by: Nordestgaard, Børge G., et al.
Published: (2012)

Total Mortality by Elevated Transferrin Saturation in Patients With Diabetes
by: Ellervik, Christina, et al.
Published: (2013)

Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts
by: Palmer, Tom M, et al.
Published: (2013)

C-reactive protein levels and body mass index: Elucidating direction of causation through reciprocal Mendelian randomization
by: Timpson, Nicholas J., et al.
Published: (2010)

Biomarker-based detection of asthma–COPD overlap syndrome in COPD populations
by: Tamada, Tsutomu, et al.
Published: (2015)

Airflow obstruction: is it asthma or is it COPD?
by: Rogliani, Paola, et al.
Published: (2016)

Microalbuminuria in Patients With Cystic Fibrosis
by: Lind-Ayres, Melanie, et al.
Published: (2011)

The role of the UPS in cystic fibrosis
by: Turnbull, Emma L, et al.
Published: (2007)

Sinonasal Manifestations in Cystic Fibrosis
by: Oomen, Karin P. Q., et al.
Published: (2012)

Calprotectin in Cystic Fibrosis
by: Rumman, Nisreen, et al.
Published: (2014)

Nontuberculous Mycobacteria in Cystic Fibrosis
by: Skolnik, Kate, et al.
Published: (2016)

Porosome in Cystic Fibrosis
by: Jena, Bhanu P.
Published: (2014)

Liver disease in cystic fibrosis
by: Kobelska-Dubiel, Natalia, et al.
Published: (2014)

COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma–COPD overlap syndrome
by: Kurashima, Kazuyoshi, et al.
Published: (2016)

A metagenomic approach to characterize temperate bacteriophage populations from Cystic Fibrosis and non-Cystic Fibrosis bronchiectasis patients
by: Tariq, Mohammad A., et al.
Published: (2015)

Optimising inhaled mannitol for cystic fibrosis in an adult population
by: Flume, Patrick A., et al.
Published: (2015)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
by: Floto, R. Andres, et al.
Published: (2016)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
by: Floto, R Andres, et al.
Published: (2016)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
by: Floto, R Andres, et al.
Published: (2016)

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
by: Quittner, Alexandra L, et al.
Published: (2016)

Hypersensitivity to parenteral antibiotics in patients with cystic fibrosis
by: Roehmel, Jobst, et al.
Published: (2014)